Navigation Links
Risk of colon cancer to be assessed by simple blood test

Colon cancer is the second most common forms of cancer, and is associated with a significant mortality. There is no single cause for colon cancer. The presence of benign growths in the colon, family history// of colon cancer, and dietary factors are some of the factors that predispose to colon cancer. The disease is completely treatable if diagnosed early.

Researchers are now trying to develop a practical test to predict a person's risk of colon cancer by looking for a particular biological marker in the blood. If successful, the test could be broadly applied to identify those who most need to be monitored with invasive but standard colonoscopy or who should make changes in their diet or in other factors to help lower their risk of developing colon cancer.

It has been suspected that genomic changes underlie cancer risk. The BRCA1 and BRCA2 genes implicated in breast and ovarian cancers are great examples, but they are applicable only to a small percentage -- less than one percent -- of women. The knowledge hasn't been translated yet into a broadly applicable way to identify individuals most at risk.

The changes associated with IGF-2 levels are linked to epigenetic mechanisms- changes in what is attached to genetic material. An epigenetic process called “imprinting normally controls the IGF-2 gene" in which the level of protein production proteins on which parent the copy came from.

For IGF-2, only the gene copy inherited from the father should be turned on, and that from the mother should be off. In about five percent to 10 percent of people, however, both copies of the gene are turned on -- a problem called loss of imprinting, leading to cancer formation.

The attempt is based on the fact that five percent to 10 percent of people have improper control of a growth-promoting gene called insulin-like growth factor 2 or IGF-2. It has been regarded that increased levels pf this protein is associated with the initia tion and subsequent development of colon cancer.

If the levels of IGF 2 are found to be linked to colon cancer and a blood test is developed to assess the levels to this protein, perhaps it could lead to a less invasive option for identification of high-risk individuals. It would be as simple as measurement of cholesterol levels as a risk factor for heart disease.
'"/>




Related medicine news :

1. Radiotherapy helps in colon cancer
2. Benefit of colonoscopy
3. Hydroxyurea derivatives kill colon cancer cells
4. Wheat wards off colon cancer
5. Defeating colon cancer
6. Calcium reduces colon cancer risk
7. Smoking risk precedes colon cancer
8. Implication of virus in colon cancer
9. New virtual colonoscopy procedure for easier colon screening
10. Long-term use of calcium supplements to prevent colon cancer
11. Aspirin may reduce he risk of colon cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/29/2017)... ... May 29, 2017 , ... Commercial door hardware needs ... businesses don’t just need to protect the lives of people such as employees, ... information, physical inventory, assets and company records too. Further, businesses aren’t just protecting ...
(Date:5/29/2017)... ... May 29, 2017 , ... The quest to develop a cure for ... if someone is cured? The virus has a knack for lying dormant in immune ... Scientists at the University of Pittsburgh’s Graduate School of Public Health announced today in ...
(Date:5/28/2017)... ... May 28, 2017 , ... Florida Pain Relief Group, a ... Fernandez-Silva, M.D., has joined its new Melbourne pain clinic. , Dr. Fernandez-Silva’s ... invasive techniques to treat and manage many types of pain. , Dr. ...
(Date:5/27/2017)... California (PRWEB) , ... May 26, 2017 , ... A ... citizens who visit a doctor for colds or respiratory issues that are not responsive ... excessive time pressure on doctors may be largely responsible for the problem both in ...
(Date:5/27/2017)... ... ... From May 21-23, hearing healthcare professionals gained a competitive edge with training from ... Downtown Hotel in Syracuse, New York. , As EarQ’s technology partner, Oticon hosts ... help them stay ahead in the industry. At the event, EarQ members learned about ...
Breaking Medicine News(10 mins):
(Date:5/10/2017)... 10, 2017 Radiology has become the number ... have also spiraled to the number one ranking as ... than ever before as the most complete and reliable ... with lower back pain an MRI may confirm a ... pain, resulting in entirely different treatment protocols.  In these ...
(Date:5/9/2017)...  Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... focused on the development of oral drug delivery ... Office has granted Oramed a patent titled, "Methods ... patent covers Oramed,s invention of an oral glucagon-like ... incretin hormone that stimulates the secretion of insulin ...
(Date:5/6/2017)... , May 5, 2017   Provista , a proven ... than 200,000 customers, today announced Jim Cunniff as ... of executive and business experience to Provista, including most recently ... in California . He assumed his new ... is a great fit for Provista," says Jody Hatcher ...
Breaking Medicine Technology: